INTERNATIONAL PATENT: SEED THERAPEUTICS US, INC. FILES APPLICATION FOR "PROTAC COMPOUNDS BINDING KEAP1 UBIQUITIN LIGASE FOR TARGETED PROTEIN DEGRADATION"

GENEVA, April 30 -- SEED THERAPEUTICS US, INC. (411 Swedeland RoadKing of Prussia, Pennsylvania 19406) filed a patent application (PCT/US2024/052069) for "PROTAC COMPOUNDS BINDING KEAP1 UBIQUITIN LIGASE FOR TARGETED PROTEIN DEGRADATION" on Oct 18, 2024. With publication no. WO/2025/085815, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AUSTIN, Joel (411 Swedeland RoadKing of Prussia, Pennsylvania 19406), JIN, Haihong (411 Swedeland RoadKing of Prussia, Pennsylvania 19406), LIU, Dong (411 Swedeland RoadKing of Prussia, Pe...